⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29572964 | 1.00 | — | — | |
| Acetic Acid SCHEMBL29148543 | 0.89 | TRIM24 (0.43) | — | |
| SCHEMBL28337559 | 0.82 | TRIM24 (0.44) | — | |
| SCHEMBL28335128 | 0.81 | TRIM24 (0.43) | — | |
| SCHEMBL25404021 | 0.77 | — | — | |
| SCHEMBL4609141 | 0.77 | — | — | |
| SCHEMBL8512088 | 0.76 | S100A4 (0.45) | — | |
| SCHEMBL346904 | 0.74 | TRIM24 (0.59) | — | |
| SCHEMBL890949 | 0.74 | S100A4 (0.43) | — | |
| SCHEMBL28338437 | 0.73 | TRIM24 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 531 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119613330-A | 3-Bromopyridine derivative, continuous synthesis method and application thereof | 苏州汉德创宏生化科技有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-113563280-B | Synthesis method of 2-cyano phenothiazine | 镇江卡博医药科技有限公司 | 2024-03-08 | — | — | CN | claimed |
| US-20260103454-A1 | MODULATORS OF HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS INC (US) | 2026-04-16 | — | — | US | disclosed |
| EP-4724543-A1 | IRIDIUM COMPLEXES USED AS PHOTOSENSITIZERS | Université Grenoble Alpes (FR) | 2026-04-15 | — | — | EP | disclosed |
| EP-4702017-A1 | SARM1 MODULATORS, PREPARATIONS, AND USES THEREOF | Sironax Ltd (KY) | 2026-03-04 | — | — | EP | disclosed |
| US-20260008767-A1 | SOMATOSTATIN MODULATORS AND USES THEREOF | CRINETICS PHARMACEUTICALS INC (US) | 2026-01-08 | — | — | US | disclosed |
| EP-4665729-A1 | DDR1 AND DDR2 INHIBITORS HAVING A DIHYDROBENZIMIDAZOLONE CORE | Redx Pharma Limited (GB) | 2025-12-24 | — | — | EP | disclosed |
| US-12435078-B2 | Pyridazinones and methods of use thereof | GFB (ABC), LLC (US) | 2025-10-07 | — | — | US | disclosed |
| EP-4616906-A2 | BENZO[A]PHENANTHRIDINE DERIVATIVES AS YAP/TAZ INHIBITORS | Sanford Burnham Prebys Medical Discovery Institute (US) | 2025-09-17 | — | — | EP | disclosed |
| EP-4612146-A1 | AHR AGONISTS | Eli Lilly and Company (US) | 2025-09-10 | — | — | EP | disclosed |
| EP-4605392-A1 | METHODS FOR TREATING CANCER | Antares Therapeutics, Inc. (US) | 2025-08-27 | — | — | EP | disclosed |
| EP-1270582-A1 | TRIPHENYLPHOSPHINE DERIVATIVE, PRODUCTION PROCESS THEREFOR, PALLADIUM COMPLEX THEREOF, AND PROCESS FOR PRODUCING BIARYL DERIVATIVE | Mitsubishi Rayon Co., Ltd. (JP) | 2003-01-02 | — | — | EP | disclosed |
| WO-2002022600-A2 | CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS | ANORMED INC. (CA) | 2002-03-21 | — | — | WO | disclosed |
| US-6353110-B1 | KEY INTERMEDIATE IN THE SYNTHESIS OF AN ENDOTHELIN ANTAGONIST; ARYLATION OF A 3-OXOPROPYLPYRIDINE WITH LITHIUM 1,3 BENZENEDIOXOLE THEN HYDROLYSIS | MERCK & CO., INC. | 2002-03-05 | — | — | US | disclosed |
| US-6022972-A | Pyridine propanoic acid derivatives | MERCK & CO., INC. (US) | 2000-02-08 | — | — | US | disclosed |
| EP-0923557-A4 | STEREOSELECTIVE DEOXYGENATION REACTION | MERCK & CO INC (US) | 1999-12-08 | — | — | EP | disclosed |
| US-5962688-A | Stereoselective deoxygenation reaction | MERCK & CO., INC. (US) | 1999-10-05 | — | — | US | disclosed |
| EP-0923557-A1 | STEREOSELECTIVE DEOXYGENATION REACTION | Merck & Co., Inc. (US) | 1999-06-23 | — | — | EP | disclosed |
| WO-1999007367-A1 | ASYMMETRIC CONJUGATE ADDITION REACTION | MERCK & CO., INC. (US) | 1999-02-18 | — | — | WO | disclosed |
| WO-1998006700-A1 | STEREOSELECTIVE DEOXYGENATION REACTION | MERCK & CO., INC. (US) | 1998-02-19 | — | — | WO | disclosed |